These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6111430)

  • 1. Analysis of iosulamide in plasma and urine: application to intravenous pharmacokinetics in rhesus monkey.
    Park GB; Biddlecome CE; Rowe EA; Kullberg MP; Edelson J
    Drug Metab Dispos; 1981; 9(1):43-7. PubMed ID: 6111430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iosulamide: a new intravenous cholangiocholecystographic medium.
    Rosenberg FJ; Ackerman JH; Nickel AR
    Invest Radiol; 1980; 15(6 Suppl):S142-7. PubMed ID: 6782035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic disposition of guanabenz in the rhesus monkey.
    Meacham RH; Chiang ST; Kick CJ; Sisenwine SF; Jusko WJ; Ruelius HW
    Drug Metab Dispos; 1981; 9(6):509-14. PubMed ID: 6120807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of diazepam on the pharmacokinetics of intravenous and epidural bupivacaine in the rhesus monkey.
    Thompson GA; Turner PA; Bridenbaugh PO; Stuebing RC; Denson DD
    Anesth Analg; 1986 Feb; 65(2):151-5. PubMed ID: 3942302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.
    Ueda CT; Ballard B; Rowland M
    J Pharmacol Exp Ther; 1977 Mar; 200(3):459-68. PubMed ID: 403278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous, intramuscular, and subcutaneous administration.
    Ferraiolo BL; Fuller GB; Burnett B; Chan E
    J Biol Response Mod; 1988 Apr; 7(2):115-22. PubMed ID: 3129541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
    Mehta SC; Boudinot FD; Lu DR
    Drug Metab Dispos; 1995 Dec; 23(12):1368-71. PubMed ID: 8689945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH
    Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL; Barriere SL; Kitt MM; Goldberg MR
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenously administered caffeine in healthy alpacas (Lama pacos) and llamas (Lama glama).
    Lakritz J; Middleton JR; Anderson DE; Linden DR; Sams RA; Tessman RK; Tyler JW
    Am J Vet Res; 2006 Jun; 67(6):1063-9. PubMed ID: 16740103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.
    Li J; Milne RW; Nation RL; Turnidge JD; Smeaton TC; Coulthard K
    J Antimicrob Chemother; 2004 May; 53(5):837-40. PubMed ID: 15044428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of primaquine in rhesus monkeys.
    Prasad RN; Garg SK; Mahajan RC; Ganguly NK
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):45-6. PubMed ID: 3988392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of magnolol after intravenous bolus and infusion in rabbits.
    Tsai TH; Chou CJ; Chen CF
    Drug Metab Dispos; 1994; 22(4):518-21. PubMed ID: 7956724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary pharmacokinetics of intravenous ciramadol in humans.
    Rosseel MT; Bogaert MG; Oosterlinck W
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):304-6. PubMed ID: 6547699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of [3H]levamisole in pigs after oral and intramuscular administration.
    Galtier P; Escoula L; Alvinerie M
    Am J Vet Res; 1983 Apr; 44(4):583-7. PubMed ID: 6869955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.